Abstract
A Retrospective Study on Inotuzumab Ozogamicin in Infants and Young Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have